Aarti Drugs Buyback of ₹59.85 crores approved by the board of directors at the meeting was held on July 21, 2023. Aarti Drugs Buyback will be done via the Tender Offer route through the stock exchange mechanism. The board of directors of the company approved the buyback by the Company of its fully paid-up equity shares having a face value of ₹10 each equity share at a price of ₹900 per Equity Share and for an aggregate amount not exceeding ₹59.85 crores from the shareholders. Check out Aarti Drugs Buyback 2023 details below:

Aarti Drugs Ltd. was established in the year 1984 and forms part of $900 Million Aarti Group of Industries with robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The Company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited. Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate etc.

Aarti Drugs Buyback History

• Aarti Drugs Buyback in 2021

Aarti Drugs Buyback 2023 Dates

Aarti Drugs Buyback 2023 Offer Details

Aarti Drugs buyback of 665,000 equity shares at a price of ₹900 per equity share. The buyback offers not to exceed ₹59.85 crores of the total buyback offer size.

Aarti Drugs Buyback 2023 Acceptance Ratio

The investor should buy around [.] shares at a current market price of ₹[.] (as of date). The calculation will be ₹2,00,000 / ₹[.] buyback price = [.] shares.

Aarti Drugs Financial Report

How to Participate in Aarti Drugs Buyback 2023

The investors are eligible for the buyback scheme who have Aarti Drugs shares in their Demat Account as the Record Date. Eligible Share Holders can participate in the Aarti Drugs Buyback 2023 scheme as per the opening form by selling their shares. The payment will be given as per the Aarti Drugsepted shares by the company under the Aarti Drugs buyback scheme.

Aarti Drugs Buyback 2023 Registrar

Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://linkintime.co.in/mipo/ipoallotment.html

Aarti Drugs Buyback 2023 Lead Managers

• Inga Ventures Pvt Ltd

Aarti Drugs Company Address

Aarti Drugs Limited
Plot No. – N-198,
MIDC, Tarapur,
Tal – Palghar, Dist. Palghar – 401506
Phone: +91 22 2401 9025
Email: [email protected]
Website: https://www.aartidrugs.co.in/

How to Apply the Aarti Drugs Buyback through Zerodha?

Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on Corporate Actions. You will see the Company Name “Aarti Drugs”. Click on Place Order. Enter your Quantity and submit Aarti Drugs Buyback Application Form.

How to Apply the Aarti Drugs Buyback through Upstox?

Log in to Upstox Application with your credentials. Select the Aarti Drugsount Section. You will see the Company Name “Aarti Drugs”. Click on Aarti Drugs Stock for Buyback. Enter your Quantity and submit Aarti Drugs Buyback Application Form.

How to Apply the Aarti Drugs Buyback through Aarti Drugs Money?

Log in to Aarti Drugs Money Application with your credentials. Select the Aarti Drugs. Enter your Quantity and submit Aarti Drugs Buyback Application Form.

Aarti Drugs Buyback 2023 FAQs

Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.

Read Also:

• SEO Powered Content & PR Distribution. Get Amplified Today.
• PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
• PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
• PlatoESG. Automotive / EVs, Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
• BlockOffsets. Modernizing Environmental Offset Ownership. Access Here.
• Source: https://ipowatch.in/aarti-drugs-buyback-2023/